CorePharma announced the launch of Dextroamphetamine Sulfate Tablets, the generic version of Shire’s Dextrostat.

Dextrostat is a Class II amphetamine indicated for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. Amphetamines are non-catecholamine, sympathomimetic amines with CNS stimulant activity. Peripheral actions include elevations of systolic and diastolic blood pressures and weak bronchodilator and respiratory stimulant action.

RELATED: ADHD Rx Linked to Lower Smoking Rates

Dextroamphetamine Sulfate is available in 5mg and 10mg strength tablets. CorePharma has begun shipping the product.

For more information call (800) 850-2719 or visit